Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration
- 17 October 2008
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 448 (1), 71-73
- https://doi.org/10.1016/j.neulet.2008.10.040
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatmentJournal of Autoimmunity, 2008
- Autologous bone marrow stem cells — properties and advantagesJournal of the Neurological Sciences, 2008
- Enhanced green fluorescent protein-expressing human mesenchymal stem cells retain neural marker expressionJournal of Neuroimmunology, 2008
- Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanismJournal of Neuroimmunology, 2008
- Mesenchymal stem cells: a new strategy for immunosuppression?Trends in Immunology, 2007
- Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitisAnnals of Neurology, 2007
- Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS miceCytotherapy, 2007
- Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microgliaThe FASEB Journal, 2006
- Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis miceJournal of Neuroscience Research, 2006
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005